Satellos Bioscience Inc. (MSLE)
NASDAQ
$8.70−$0.0100 (−0.11%) on the dayAs of the close; data may be delayed.
MSLE price, last 12 months
Key stats
- Previous close
- $8.71
- Open
- $9.00
- Day range
- $8.54 – $9.00
- 52-week range
- $5.44 – $13.39
- Volume
- 31.8K
- Avg volume (20 days)
- 31.1K
- Market cap
- $184.6M
Performance
1W−6.7%
1M−7.1%
3M+22.9%
6M+25.5%
YTD—
1Y—
Technicals and fundamentals
About Satellos Bioscience Inc.
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
- Listed on
- NASDAQ
- Market cap
- $184.6M